Back to Search
Start Over
Figure S9 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Asf1a KO and anti-PD-1 combination therapy primes and activates T cells that can recognize specific tumor-associated antigen
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3a0315fe18b87b225e8e70b3dac38ad1